 |
PDBsum entry 1q02
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Protein binding
|
PDB id
|
|
|
|
1q02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
278:37409-37412
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone.
|
|
B.Ciani,
R.Layfield,
J.R.Cavey,
P.W.Sheppard,
M.S.Searle.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The p62 protein (also known as SQSTM1) mediates diverse cellular functions
including control of NFkappaB signaling and transcriptional activation. p62
binds non-covalently to ubiquitin and co-localizes with ubiquitylated inclusions
in a number of human protein aggregation diseases. Mutations in the gene
encoding p62 cause Paget's disease of bone (PDB), a common disorder of the
elderly characterized by excessive bone resorption and formation. All of the p62
PDB mutations identified to date cluster within the C-terminal region of the
protein, which shows low sequence identity to previously characterized
ubiquitin-associated (UBA) domains. We report the first NMR structure of a
recombinant polypeptide that contains the C-terminal UBA domain of the human p62
protein (residues 387-436). This sequence, which confers multiubiquitin chain
binding, forms a compact three-helix bundle with a structure analogous to the
UBA domains of HHR23A but with differences in the loop regions connecting
helices that may be involved in binding accessory proteins. We show that the
Pro392 --> Leu PDB substitution mutation modifies the structure of the UBA
domain by extending the N terminus of helix 1. In contrast to the p62 PDB
deletion mutations that remove the UBA domain and ablate multiubiquitin chain
binding, the Pro392 --> Leu substitution does not affect interaction of the UBA
domain with multiubiquitin chains. Thus, phenotypically identical substitution
and deletion mutations do not appear to predispose to PDB through a mechanism
dependent on a common loss of ubiquitin chain binding by p62.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. a, domain structure of the p62 protein and Paget's
disease of bone mutation sites (SH2, AID, ZZ, and TRAF6 refer to
binding sites for the SH2 domain of p56^lck, aPKC, RIP, and
TRAF6, respectively), and b, sequence alignment of the p62-UBA
domain with the HHR23A-UBA domains (alignment from SMART data
base; see Ref. 7).
|
 |
Figure 3.
FIG. 3. a, ribbon structure of the p62-UBA domain with key
side chains highlighted with MOLMOL (30); b, overlaid backbone
of the p62-UBA (light) and UBA (2) of HHR23A (dark) (Protein
Data Bank code 1DV0 [PDB]
) showing the helical alignment and differences in loop 1
incorporating Glu409 and Gly410 in p62.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
37409-37412)
copyright 2003.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Seidel,
W.F.den Dunnen,
C.Schultz,
H.Paulson,
S.Frank,
R.A.de Vos,
E.R.Brunt,
T.Deller,
H.H.Kampinga,
and
U.Rüb
(2010).
Axonal inclusions in spinocerebellar ataxia type 3.
|
| |
Acta Neuropathol,
120,
449-460.
|
 |
|
|
|
|
 |
P.Y.Chung,
G.Beyens,
S.Boonen,
S.Papapoulos,
P.Geusens,
M.Karperien,
F.Vanhoenacker,
L.Verbruggen,
E.Fransen,
J.Van Offel,
S.Goemaere,
H.G.Zmierczak,
R.Westhovens,
J.P.Devogelaer,
and
W.Van Hul
(2010).
The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.
|
| |
Hum Genet,
128,
615-626.
|
 |
|
|
|
|
 |
A.Falchetti,
M.Di Stefano,
F.Marini,
S.Ortolani,
M.F.Ulivieri,
S.Bergui,
L.Masi,
C.Cepollaro,
M.Benucci,
O.Di Munno,
M.Rossini,
S.Adami,
A.Del Puente,
G.Isaia,
F.Torricelli,
and
M.L.Brandi
(2009).
Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone.
|
| |
Calcif Tissue Int,
84,
20-37.
|
 |
|
|
|
|
 |
A.Kontrogianni-Konstantopoulos,
M.A.Ackermann,
A.L.Bowman,
S.V.Yap,
and
R.J.Bloch
(2009).
Muscle giants: molecular scaffolds in sarcomerogenesis.
|
| |
Physiol Rev,
89,
1217-1267.
|
 |
|
|
|
|
 |
J.Gal,
A.L.Ström,
D.M.Kwinter,
R.Kilty,
J.Zhang,
P.Shi,
W.Fu,
M.W.Wooten,
and
H.Zhu
(2009).
Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism.
|
| |
J Neurochem,
111,
1062-1073.
|
 |
|
|
|
|
 |
C.L.Evans,
J.E.Long,
T.R.Gallagher,
J.D.Hirst,
and
M.S.Searle
(2008).
Conformation and dynamics of the three-helix bundle UBA domain of p62 from experiment and simulation.
|
| |
Proteins,
71,
227-240.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.R.Stoddard,
A.D.Brooks,
B.A.Eskin,
and
G.J.Johannes
(2008).
Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine.
|
| |
Int J Med Sci,
5,
189-196.
|
 |
|
|
|
|
 |
P.Y.Chung,
G.Beyens,
N.Guañabens,
S.Boonen,
S.Papapoulos,
M.Karperien,
M.Eekhoff,
L.Van Wesenbeeck,
K.Jennes,
P.Geusens,
E.Offeciers,
J.Van Offel,
R.Westhovens,
H.Zmierczak,
J.P.Devogelaer,
and
W.Van Hul
(2008).
Founder effect in different European countries for the recurrent P392L SQSTM1 mutation in Paget's Disease of Bone.
|
| |
Calcif Tissue Int,
83,
34-42.
|
 |
|
|
|
|
 |
C.Collet,
L.Michou,
M.Audran,
S.Chasseigneaux,
P.Hilliquin,
T.Bardin,
I.Lemaire,
F.Cornélis,
J.M.Launay,
P.Orcel,
and
J.L.Laplanche
(2007).
Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations.
|
| |
J Bone Miner Res,
22,
310-317.
|
 |
|
|
|
|
 |
P.Peschard,
G.Kozlov,
T.Lin,
I.A.Mirza,
A.M.Berghuis,
S.Lipkowitz,
M.Park,
and
K.Gehring
(2007).
Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b.
|
| |
Mol Cell,
27,
474-485.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Daroszewska,
and
S.H.Ralston
(2006).
Mechanisms of disease: genetics of Paget's disease of bone and related disorders.
|
| |
Nat Clin Pract Rheumatol,
2,
270-277.
|
 |
|
|
|
|
 |
E.D.Lowe,
N.Hasan,
J.F.Trempe,
L.Fonso,
M.E.Noble,
J.A.Endicott,
L.N.Johnson,
and
N.R.Brown
(2006).
Structures of the Dsk2 UBL and UBA domains and their complex.
|
| |
Acta Crystallogr D Biol Crystallogr,
62,
177-188.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.R.Cavey,
S.H.Ralston,
P.W.Sheppard,
B.Ciani,
T.R.Gallagher,
J.E.Long,
M.S.Searle,
and
R.Layfield
(2006).
Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone.
|
| |
Calcif Tissue Int,
78,
271-277.
|
 |
|
|
|
|
 |
K.H.Yip,
H.Feng,
N.J.Pavlos,
M.H.Zheng,
and
J.Xu
(2006).
p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
|
| |
Am J Pathol,
169,
503-514.
|
 |
|
|
|
|
 |
M.W.Wooten,
X.Hu,
J.R.Babu,
M.L.Seibenhener,
T.Geetha,
M.G.Paine,
and
M.C.Wooten
(2006).
Signaling, Polyubiquitination, Trafficking, and Inclusions: Sequestosome 1/p62's Role in Neurodegenerative Disease.
|
| |
J Biomed Biotechnol,
2006,
62079.
|
 |
|
|
|
|
 |
Y.G.Chang,
A.X.Song,
Y.G.Gao,
Y.H.Shi,
X.J.Lin,
X.T.Cao,
D.H.Lin,
and
H.Y.Hu
(2006).
Solution structure of the ubiquitin-associated domain of human BMSC-UbP and its complex with ubiquitin.
|
| |
Protein Sci,
15,
1248-1259.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Falchetti,
M.Di Stefano,
F.Marini,
F.Del Monte,
A.Gozzini,
L.Masi,
A.Tanini,
A.Amedei,
A.Carossino,
G.Isaia,
and
M.L.Brandi
(2005).
Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family.
|
| |
Arthritis Res Ther,
7,
R1289-R1295.
|
 |
|
|
|
|
 |
A.Ohno,
J.Jee,
K.Fujiwara,
T.Tenno,
N.Goda,
H.Tochio,
H.Kobayashi,
H.Hiroaki,
and
M.Shirakawa
(2005).
Structure of the UBA domain of Dsk2p in complex with ubiquitin molecular determinants for ubiquitin recognition.
|
| |
Structure,
13,
521-532.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.D.Roodman,
and
J.J.Windle
(2005).
Paget disease of bone.
|
| |
J Clin Invest,
115,
200-208.
|
 |
|
|
|
|
 |
J.F.Trempe,
N.R.Brown,
E.D.Lowe,
C.Gordon,
I.D.Campbell,
M.E.Noble,
and
J.A.Endicott
(2005).
Mechanism of Lys48-linked polyubiquitin chain recognition by the Mud1 UBA domain.
|
| |
EMBO J,
24,
3178-3189.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.R.Babu,
T.Geetha,
and
M.W.Wooten
(2005).
Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation.
|
| |
J Neurochem,
94,
192-203.
|
 |
|
|
|
|
 |
J.R.Cavey,
S.H.Ralston,
L.J.Hocking,
P.W.Sheppard,
B.Ciani,
M.S.Searle,
and
R.Layfield
(2005).
Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations.
|
| |
J Bone Miner Res,
20,
619-624.
|
 |
|
|
|
|
 |
L.A.Ehrlich,
and
G.D.Roodman
(2005).
The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma.
|
| |
Immunol Rev,
208,
252-266.
|
 |
|
|
|
|
 |
S.Raasi,
R.Varadan,
D.Fushman,
and
C.M.Pickart
(2005).
Diverse polyubiquitin interaction properties of ubiquitin-associated domains.
|
| |
Nat Struct Mol Biol,
12,
708-714.
|
 |
|
|
|
|
 |
E.W.Eekhoff,
M.Karperien,
D.Houtsma,
A.H.Zwinderman,
C.Dragoiescu,
A.L.Kneppers,
and
S.E.Papapoulos
(2004).
Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations.
|
| |
Arthritis Rheum,
50,
1650-1654.
|
 |
|
|
|
|
 |
L.J.Hocking,
G.J.Lucas,
A.Daroszewska,
T.Cundy,
G.C.Nicholson,
J.Donath,
J.P.Walsh,
C.Finlayson,
J.R.Cavey,
B.Ciani,
P.W.Sheppard,
M.S.Searle,
R.Layfield,
and
S.H.Ralston
(2004).
Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.
|
| |
J Bone Miner Res,
19,
1122-1127.
|
 |
|
|
|
|
 |
M.L.Seibenhener,
J.R.Babu,
T.Geetha,
H.C.Wong,
N.R.Krishna,
and
M.W.Wooten
(2004).
Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation.
|
| |
Mol Cell Biol,
24,
8055-8068.
|
 |
|
|
|
|
 |
R.Layfield,
and
L.J.Hocking
(2004).
SQSTM1 and Paget's disease of bone.
|
| |
Calcif Tissue Int,
75,
347-357.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |